Trial of Selumetinib in Patients With Neurofibromatosis Type II Related Tumors
Conditions: Neurofibromatosis 2; Vestibular Schwannoma; Meningioma; Ependymoma; Glioma Intervention: Drug: Selumetinib Sponsors: Children's Hospital Medical Center, Cincinnati; AstraZeneca Not yet recruiting - verified March 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: AstraZeneca | Brain Tumor | Children | Ependymoma | Glioma | Men | Neurofibromatosis | Neurology